Last updated 2026-06-18
- Raised $50k grant, Jan 2015
Total raised
$50K
Last: Grant 2015-01
Stage
Pre-Funding
Founded
2014
Headcount
6
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences
About
Novitero is a computational drug design and development company working to enable precise and effective cancer treatments. The companys technology is designed to proactively combat cancer by previewing its mutational activities and overcoming its resistance to therapies. Noviteros goal is to predict and bypass the potential mutations that cancer may adopt to resist therapies. The company uses its computational technologies to predict the mutational fingerprints implicated in drug resistance to various therapeutic targets. It then designs, validates, and out-licenses new drugs that bypass these mutations.
Funding history · 1 round · $50K total
2015-01
Grant
$50K
Q&A
- What is Novitero's primary focus?
- Novitero is a computational drug design and development company focused on enabling precise and effective cancer treatments by proactively combating cancer's mutational activities and overcoming resistance to therapies.
- When was Novitero founded?
- Novitero was founded in February 2014.
- What is the current status of Novitero?
- Novitero is currently inactive, having ceased operations in January 2021.
- What was Novitero's total funding raised?
- Novitero raised a total of $50,000.
- When did Novitero receive its last funding round?
- Novitero received a Grant round in January 2015, amounting to $50,000.
- Who was the founder and CEO of Novitero?
- The founder and CEO of Novitero was Itzchak Angel, PhD.
- What is Novitero's primary sector?
- Novitero's primary sector is Health Tech & Life Sciences, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
Team · 1
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsMolecules
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology
Business model
B2B
Highlights
1 PatentsVerified
Tags
drug-designdrug-discoverytargeted-cancer-therapycancer-therapypersonalizationpharma-companiesbioinformatics
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | novitero.com/ |
|---|
Identifiers & details
| Founded | 2014-2 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Jan 2021 ceased to operate |